Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat
Pharmaceutical Technology
NOVEMBER 28, 2024
The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.
Thu.Nov 28, 2024
246 
Drugs Like Ozempic May Have a Shrinking Effect on The Heart
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 28, 2024
Cardiac muscle cells in mice. (Martens et al., The Lancet, 2024) Popular weight loss drugs like Ozempic and Wegovy are showing incredible short-term benefits – from boosted metabolic health to pain relief to addiction and cognitive health.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
Pharmaceutical Technology
NOVEMBER 28, 2024
There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.
PCI to integrate pharmacists’ database with Healthcare Professional Registry
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 28, 2024
The Pharmacy Council of India (PCI) has sought all the pharmacists who don’t have the ABHA (Ayushman Bharat Health Account) number to attain a number and ensure registration with the DIGI-PHARMed profile with the ABHA number on immediate basis, as part of its efforts to integrate the pharmacists’ list with the Healthcare Professional Registry (HPR).
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Pharmaceutical Technology
NOVEMBER 28, 2024
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).
Axsome Therapeutics’ Reboxetine Promises Long-Term Symptom Relief in Narcolepsy
XTalks
NOVEMBER 28, 2024
Axsome Therapeutics has released findings from its ENCORE Phase III trial, demonstrating that their investigational drug AXS-12 (reboxetine) significantly reduces cataplexy attacks, improves excessive daytime sleepiness and enhances overall functioning in individuals with narcolepsy. These results highlight reboxetine’s potential as a comprehensive treatment for this challenging sleep-wake disorder.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
FDA probing cancer cases with Bluebird's CALD gene therapy
pharmaphorum
NOVEMBER 28, 2024
The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD.
Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition
Pharmaceutical Technology
NOVEMBER 28, 2024
The relationship between climate change and infectious disease is raising new questions for pharmaceutical and clinical leaders.
Grifols slides as Brookfield pulls out of takeover talks
pharmaphorum
NOVEMBER 28, 2024
Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's shares.
Advanz Pharma’s liver disease drug pulled from European market after court hearing
Pharmaceutical Technology
NOVEMBER 28, 2024
This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024.
Neuralink unveils trial linking brain implant to robotic arm
pharmaphorum
NOVEMBER 28, 2024
Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm.
EC approves GSK’s Menveo vaccine presentation for IMD
Pharmaceutical Technology
NOVEMBER 28, 2024
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
Applied Tx craters as FDA rejects lead product candidate
pharmaphorum
NOVEMBER 28, 2024
Applied Therapeutics plummets after the FDA turns down its marketing application for govorestat as a treatment for galactosaemia
New injection offers hope for asthma and COPD attacks
Pharma Times
NOVEMBER 28, 2024
Injection significantly reduces need for further treatment
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Exciting start-ups and developments in drug discovery
Drug Discovery World podcast
NOVEMBER 28, 2024
This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘ What Lithuania offers life sciences start-ups ’ and ‘ Avoiding detection – the cancer cells evading the body’s natural defence ’.
UK grants promising innovative medicine status to CIDP drug
Pharma Times
NOVEMBER 28, 2024
Therapy for autoimmune disorder shows potential
Designing personalised digital experiences that engage healthcare professionals
pharmaphorum
NOVEMBER 28, 2024
Designing personalised digital experiences for healthcare professionals (HCPs) involves collaboration between digital designers and data experts. Learn how to engage HCPs effectively with tailored digital solutions.
Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more
Pharmaceutical Commerce
NOVEMBER 28, 2024
The latest news for pharma industry insiders.
LEAP HR: Life Sciences West
pharmaphorum
NOVEMBER 28, 2024
Join us in San Francisco, CA this April for LEAP HR: Life Sciences West to network with 200+ senior HR leaders
Trump agency nominations show pharma industry as divided as US
Pharmaceutical Technology
NOVEMBER 28, 2024
Confirmation of Trump's nominations for appointments is not yet assured and the Senate will vote to approve them early in 2025.
Study finds AZ's benralizumab a 'game-changer' in asthma
pharmaphorum
NOVEMBER 28, 2024
Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Pharmaceutical Technology
NOVEMBER 28, 2024
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content